Pharmaceutical News and Articles

2,770 Cases of Arboviral Disease Reported in 48 States and D.C. in 2023

In 2023, 48 states and the District of Columbia reported 2,770 human arboviral disease cases, with West Nile Virus (WNV) being the most common, according to res

Aldeyra Therapeutics Resubmits Reproxalap New Drug Application for the Treatment of Dry Eye Disease

Digital Tool Potentially Predicts Childhood Asthma

TUESDAY, June 17, 2025 A new digital tool can flag kids who are at risk for developing childhood asthma, researchers report. The tool scans electronic health da

Electroshock Therapy Appears To Reduce Suicide Risk Among People With Depression

TUESDAY, June 17, 2025 People with severe depression who receive electroshock therapy are significantly less likely to commit suicide, a new evidence review say

Blood Pressure Diet Helps Type 2 Diabetics

TUESDAY, June 17, 2025 A diet meant to lower blood pressure also can be effective in treating type 2 diabetes after a few tweaks, a new clinical trial indicates

Dementia Caregivers Themselves At Higher Risk For Brain Aging

TUESDAY, June 17, 2025 People caring for people with dementia might face future risk with their own brain aging due to lifestyle factors, a new study says. Near

Psychedelics Can Help Cancer Patients Battling Depression

TUESDAY, June 17, 2025 Magic mushrooms might be key to quelling depression among people battling cancer. A single dose of psilocybin provided sustained reductio

ADHD Stimulants Can Be Safely Prescribed Via Telehealth, Study Argues

MONDAY, June 16, 2025 People with ADHD might be prescribed their meds remotely without increasing their risk of addiction, a new study says. Experts have worrie

Texas Invests $50M in Psychedelic Drug Research into Ibogaine to Treat Addiction

MONDAY, June 16, 2025 Texas has moved to fund research into ibogaine, a psychedelic drug that may help treat addiction, depression, and brain injuries. Gov. Gre

Global Incidence Rate of Rheumatoid Arthritis Increased From 1990 to 2021

The incidence rate of rheumatoid arthritis (RA) increased globally from 1990 to 2021, with the heaviest burden born by regions with a high sociodemographic inde